Despite the medical benefits, the production of peptides could be more efficient and environmentally costly. Peptide synthesis, mainly through solid-phase (SPPS) synthesis, involves substantial quantities of organic solvents, leading to significant industrial waste. Experts like Rodney Lax, a former business development manager at PolyPeptide, and Matteo Villain, a vice president at Piramal Pharma Solutions, express concerns about the sustainability of current production methods.